{"doi":"10.1016/j.lungcan.2020.01.008","title":"Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study","abstract":null,"journal":"Lung Cancer","year":2020,"id":18925,"datarank":1.0262445503341295,"base_score":3.258096538021482,"endowment":3.258096538021482,"self_citation_contribution":0.4887144807032224,"citation_network_contribution":0.5375300696309071,"self_endowment_contribution":0.4887144807032224,"citer_contribution":0.5375300696309071,"corpus_percentile":null,"corpus_rank":null,"citation_count":25,"citer_count":18,"citers_with_citation_signal":13,"citers_with_endowment":13,"datacite_reuse_total":2,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":129813,"name":"Tatsuya Yoshida","orcid":null,"position":1,"is_corresponding":false},{"id":129814,"name":"Tetsuo Akimoto","orcid":"0000-0003-0881-1345","position":2,"is_corresponding":false},{"id":128948,"name":"Kentaro Sakamaki","orcid":null,"position":3,"is_corresponding":false},{"id":129475,"name":"Akira Ono","orcid":"0000-0001-5705-9423","position":4,"is_corresponding":false},{"id":129815,"name":"Takashi Seto","orcid":null,"position":5,"is_corresponding":false},{"id":129816,"name":"Makoto Nishio","orcid":null,"position":6,"is_corresponding":false},{"id":129817,"name":"Noboru Yamamoto","orcid":null,"position":7,"is_corresponding":false},{"id":129818,"name":"Toyoaki Hida","orcid":null,"position":8,"is_corresponding":false},{"id":129819,"name":"Hiroaki Okamoto","orcid":null,"position":9,"is_corresponding":false},{"id":33771,"name":"Takayasu Kurata","orcid":"0000-0003-4123-3567","position":10,"is_corresponding":false},{"id":129820,"name":"Miyako Satouchi","orcid":null,"position":11,"is_corresponding":false},{"id":129821,"name":"Koichi Goto","orcid":null,"position":12,"is_corresponding":false},{"id":129822,"name":"Takeharu Yamanaka","orcid":null,"position":13,"is_corresponding":false},{"id":129823,"name":"Yuichiro Ohe","orcid":null,"position":14,"is_corresponding":false},{"id":129812,"name":"Seiji Niho","orcid":"0000-0001-9480-5923","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.258096538021482,"endowment":3.258096538021482,"datacite_reuse_total":2,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"31955002","pmcid":null,"openalex_id":"https://openalex.org/W2999684312","authors":[],"funders":[{"funder_name":"AMED","grant_id":"JP19ck0106312","title":null}],"total_grants":1,"fwci":1.6222,"citation_percentile":0.86162739,"influential_citations":1,"citation_trend":[{"year":2021,"count":5},{"year":2022,"count":5},{"year":2023,"count":3},{"year":2024,"count":4},{"year":2025,"count":5},{"year":2026,"count":3}],"oa_status":"closed","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0169500220300192?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0169500220300192?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.lungcan.2020.01.008","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/31955002","host_type":"repository"}],"fields_of_study":["Lung Cancer Diagnosis and Treatment","Lung Cancer Research Studies","Lung Cancer Treatments and Mutations","Medicine","Adenocarcinoma of Lung","Adult","Aged","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Chemoradiotherapy","Cisplatin","Drug Combinations","Female","Follow-Up Studies","Humans","Lung Neoplasms","Male","Middle Aged","Oxonic Acid","Pemetrexed","Prognosis","Survival Rate","Tegafur"],"mesh_terms":["Pemetrexed","Adenocarcinoma of Lung","Adult","Aged","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Cisplatin","Drug Combinations","Female","Follow-Up Studies","Tegafur","Humans","Lung Neoplasms","Male","Middle Aged","Oxonic Acid","Prognosis","Survival Rate","Chemoradiotherapy"],"keywords":["Pemetrexed","Medicine","Cisplatin","Hazard ratio","Internal medicine","Lung cancer","Chemoradiotherapy","Chemotherapy","Phases of clinical research","Clinical endpoint","Confidence interval","Oncology","Randomized controlled trial","S-1","Locally Advanced Non-squamous Non-small Cell Lung Cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.18094488.v1","title":"Additional file 1 of Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.18094488","title":"Additional file 1 of Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-04T00:32:11.230516Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}